BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 33227575)

  • 1. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet and gut microbiome interactions in gynecologic cancer.
    AlHilli MM; Bae-Jump V
    Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.
    Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C
    Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and adaptive immunity in schizophrenia.
    Agorastos A; Bozikas VP
    Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.
    Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW
    Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review).
    Zhou Y; Han W; Feng Y; Wang Y; Sun T; Xu J
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38847233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the emerging role of the microbiome in cancer immunotherapy.
    Fessler J; Matson V; Gajewski TF
    J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy.
    Wang M; Yang G; Tian Y; Zhang Q; Liu Z; Xin Y
    Front Immunol; 2023; 14():1183331. PubMed ID: 37457738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome and cancer immunotherapy.
    Chilakapati SR; Ricciuti J; Zsiros E
    Curr Opin Biotechnol; 2020 Oct; 65():114-117. PubMed ID: 32192986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
    Amara S; Yang LV; Tiriveedhi V; Muzaffar M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting microbiome, drug metabolism, and drug delivery in oncology.
    Sumiyoshi A; Fujii H; Okuma Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114902. PubMed ID: 37263544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.